Do analysts prefer RNXT or MODD?

RenovoRx presently has a consensus price target of $8.50, suggesting a potential upside of 402.96%. Given RenovoRx's stronger consensus rating and higher possible upside, equities analysts plainly believe RenovoRx is more favorable than Modular Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RenovoRx 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.75 Modular Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is RNXT or MODD more profitable?

Modular Medical has a net margin of 0.00% compared to RenovoRx's net margin of -621.71%. RenovoRx's return on equity of -135.11% beat Modular Medical's return on equity. Company Net Margins Return on Equity Return on Assets RenovoRx -621.71% -135.11% -101.91% Modular Medical N/A -292.14% -222.79%

Does the media refer more to RNXT or MODD?

In the previous week, Modular Medical had 1 more articles in the media than RenovoRx. MarketBeat recorded 2 mentions for Modular Medical and 1 mentions for RenovoRx. RenovoRx's average media sentiment score of 1.92 beat Modular Medical's score of 0.64 indicating that RenovoRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RenovoRx 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Modular Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate LUNG or MODD?

Pulmonx currently has a consensus price target of $7.67, suggesting a potential upside of 270.37%. Given Pulmonx's stronger consensus rating and higher probable upside, equities analysts plainly believe Pulmonx is more favorable than Modular Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pulmonx 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Modular Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is LUNG or MODD more profitable?

Modular Medical has a net margin of 0.00% compared to Pulmonx's net margin of -55.03%. Pulmonx's return on equity of -96.66% beat Modular Medical's return on equity. Company Net Margins Return on Equity Return on Assets Pulmonx -55.03% -96.66% -38.32% Modular Medical N/A -292.14% -222.79%

Does the media favor LUNG or MODD?

In the previous week, Modular Medical had 1 more articles in the media than Pulmonx. MarketBeat recorded 2 mentions for Modular Medical and 1 mentions for Pulmonx. Modular Medical's average media sentiment score of 0.64 beat Pulmonx's score of 0.00 indicating that Modular Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pulmonx 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Modular Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer HYPR or MODD?

Hyperfine currently has a consensus target price of $2.03, suggesting a potential upside of 159.12%. Given Hyperfine's stronger consensus rating and higher probable upside, equities analysts plainly believe Hyperfine is more favorable than Modular Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hyperfine 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Modular Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is HYPR or MODD more profitable?

Modular Medical has a net margin of 0.00% compared to Hyperfine's net margin of -210.75%. Hyperfine's return on equity of -97.88% beat Modular Medical's return on equity. Company Net Margins Return on Equity Return on Assets Hyperfine -210.75% -97.88% -61.81% Modular Medical N/A -292.14% -222.79%

Does the media favor HYPR or MODD?

In the previous week, Hyperfine had 5 more articles in the media than Modular Medical. MarketBeat recorded 7 mentions for Hyperfine and 2 mentions for Modular Medical. Modular Medical's average media sentiment score of 0.64 beat Hyperfine's score of 0.28 indicating that Modular Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hyperfine 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Modular Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend ECOR or MODD?

electroCore presently has a consensus target price of $18.00, indicating a potential upside of 54.11%. Given electroCore's stronger consensus rating and higher possible upside, research analysts clearly believe electroCore is more favorable than Modular Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score electroCore 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Modular Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor ECOR or MODD?

In the previous week, Modular Medical had 1 more articles in the media than electroCore. MarketBeat recorded 2 mentions for Modular Medical and 1 mentions for electroCore. Modular Medical's average media sentiment score of 0.64 beat electroCore's score of 0.50 indicating that Modular Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment electroCore 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Modular Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate MODD or CVRX?

CVRx has a consensus price target of $5.30, indicating a potential upside of 74.34%. Given CVRx's stronger consensus rating and higher possible upside, analysts clearly believe CVRx is more favorable than Modular Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Modular Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 CVRx 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17

Is MODD or CVRX more profitable?

Modular Medical has a net margin of 0.00% compared to CVRx's net margin of -84.93%. CVRx's return on equity of -152.35% beat Modular Medical's return on equity. Company Net Margins Return on Equity Return on Assets Modular Medical N/A -292.14% -222.79% CVRx -84.93% -152.35% -50.93%

Does the media prefer MODD or CVRX?

In the previous week, Modular Medical and Modular Medical both had 2 articles in the media. Modular Medical's average media sentiment score of 0.64 beat CVRx's score of -0.13 indicating that Modular Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Modular Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CVRx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Modular Medical (MODD) Competitors

$2.20 +0.05 (+2.33%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$2.17 -0.03 (-1.14%)

As of 09/18/2026 06:38 PM Eastern

Compare

MODD vs. RNXT, LUNG, HYPR, ECOR, and CVRX

Should you buy Modular Medical stock or one of its competitors? Modular Medical's main competitors and comparable companies include RenovoRx (RNXT), Pulmonx (LUNG), Hyperfine (HYPR), electroCore (ECOR), and CVRx (CVRX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Modular Medical compare to RenovoRx?

RenovoRx (NASDAQ:RNXT) and Modular Medical (NASDAQ:MODD) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, dividends, earnings and analyst recommendations.

RenovoRx presently has a consensus price target of $8.50, suggesting a potential upside of 402.96%. Given RenovoRx's stronger consensus rating and higher possible upside, equities analysts plainly believe RenovoRx is more favorable than Modular Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RenovoRx	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.75
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

RenovoRx has a beta of 1.12, meaning that its share price is 12% more volatile than the broader market. Comparatively, Modular Medical has a beta of 0.45, meaning that its share price is 55% less volatile than the broader market.

Modular Medical has a net margin of 0.00% compared to RenovoRx's net margin of -621.71%. RenovoRx's return on equity of -135.11% beat Modular Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RenovoRx	-621.71%	-135.11%	-101.91%
Modular Medical	N/A	-292.14%	-222.79%

3.1% of RenovoRx shares are owned by institutional investors. Comparatively, 27.5% of Modular Medical shares are owned by institutional investors. 9.4% of RenovoRx shares are owned by insiders. Comparatively, 7.1% of Modular Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Modular Medical had 1 more articles in the media than RenovoRx. MarketBeat recorded 2 mentions for Modular Medical and 1 mentions for RenovoRx. RenovoRx's average media sentiment score of 1.92 beat Modular Medical's score of 0.64 indicating that RenovoRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RenovoRx	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Modular Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

RenovoRx has higher revenue and earnings than Modular Medical. RenovoRx is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RenovoRx	$1.12M	68.10	-$11.17M	-$0.31	N/A
Modular Medical	N/A	N/A	-$28.24M	-$8.69	N/A

Summary

RenovoRx beats Modular Medical on 12 of the 16 factors compared between the two stocks.

How does Modular Medical compare to Pulmonx?

Pulmonx (NASDAQ:LUNG) and Modular Medical (NASDAQ:MODD) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, media sentiment, profitability, dividends, risk and analyst recommendations.

Pulmonx has a beta of 0.34, indicating that its stock price is 66% less volatile than the broader market. Comparatively, Modular Medical has a beta of 0.45, indicating that its stock price is 55% less volatile than the broader market.

Modular Medical has lower revenue, but higher earnings than Pulmonx. Pulmonx is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pulmonx	$90.50M	0.98	-$54M	-$1.16	N/A
Modular Medical	N/A	N/A	-$28.24M	-$8.69	N/A

Modular Medical has a net margin of 0.00% compared to Pulmonx's net margin of -55.03%. Pulmonx's return on equity of -96.66% beat Modular Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pulmonx	-55.03%	-96.66%	-38.32%
Modular Medical	N/A	-292.14%	-222.79%

91.0% of Pulmonx shares are held by institutional investors. Comparatively, 27.5% of Modular Medical shares are held by institutional investors. 7.5% of Pulmonx shares are held by insiders. Comparatively, 7.1% of Modular Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Modular Medical had 1 more articles in the media than Pulmonx. MarketBeat recorded 2 mentions for Modular Medical and 1 mentions for Pulmonx. Modular Medical's average media sentiment score of 0.64 beat Pulmonx's score of 0.00 indicating that Modular Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pulmonx	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Modular Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Pulmonx currently has a consensus price target of $7.67, suggesting a potential upside of 270.37%. Given Pulmonx's stronger consensus rating and higher probable upside, equities analysts plainly believe Pulmonx is more favorable than Modular Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pulmonx	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Pulmonx beats Modular Medical on 9 of the 15 factors compared between the two stocks.

How does Modular Medical compare to Hyperfine?

Hyperfine (NASDAQ:HYPR) and Modular Medical (NASDAQ:MODD) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations, media sentiment and profitability.

15.0% of Hyperfine shares are held by institutional investors. Comparatively, 27.5% of Modular Medical shares are held by institutional investors. 26.3% of Hyperfine shares are held by company insiders. Comparatively, 7.1% of Modular Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Modular Medical has a net margin of 0.00% compared to Hyperfine's net margin of -210.75%. Hyperfine's return on equity of -97.88% beat Modular Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hyperfine	-210.75%	-97.88%	-61.81%
Modular Medical	N/A	-292.14%	-222.79%

Hyperfine currently has a consensus target price of $2.03, suggesting a potential upside of 159.12%. Given Hyperfine's stronger consensus rating and higher probable upside, equities analysts plainly believe Hyperfine is more favorable than Modular Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hyperfine	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Hyperfine has a beta of 1.41, suggesting that its share price is 41% more volatile than the broader market. Comparatively, Modular Medical has a beta of 0.45, suggesting that its share price is 55% less volatile than the broader market.

Modular Medical has lower revenue, but higher earnings than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hyperfine	$11.40M	7.30	-$35.57M	-$0.38	N/A
Modular Medical	N/A	N/A	-$28.24M	-$8.69	N/A

In the previous week, Hyperfine had 5 more articles in the media than Modular Medical. MarketBeat recorded 7 mentions for Hyperfine and 2 mentions for Modular Medical. Modular Medical's average media sentiment score of 0.64 beat Hyperfine's score of 0.28 indicating that Modular Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hyperfine	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Modular Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Hyperfine beats Modular Medical on 10 of the 15 factors compared between the two stocks.

How does Modular Medical compare to electroCore?

electroCore (NASDAQ:ECOR) and Modular Medical (NASDAQ:MODD) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, media sentiment, valuation and risk.

Modular Medical has a net margin of 0.00% compared to electroCore's net margin of -39.96%. Modular Medical's return on equity of -292.14% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
electroCore	-39.96%	-1,956.38%	-81.35%
Modular Medical	N/A	-292.14%	-222.79%

26.7% of electroCore shares are held by institutional investors. Comparatively, 27.5% of Modular Medical shares are held by institutional investors. 7.8% of electroCore shares are held by company insiders. Comparatively, 7.1% of Modular Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

electroCore has higher revenue and earnings than Modular Medical. electroCore is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
electroCore	$32.03M	3.29	-$13.97M	-$1.66	N/A
Modular Medical	N/A	N/A	-$28.24M	-$8.69	N/A

In the previous week, Modular Medical had 1 more articles in the media than electroCore. MarketBeat recorded 2 mentions for Modular Medical and 1 mentions for electroCore. Modular Medical's average media sentiment score of 0.64 beat electroCore's score of 0.50 indicating that Modular Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
electroCore	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Modular Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

electroCore presently has a consensus target price of $18.00, indicating a potential upside of 54.11%. Given electroCore's stronger consensus rating and higher possible upside, research analysts clearly believe electroCore is more favorable than Modular Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

electroCore has a beta of 1, indicating that its stock price has a similar volatility profile to the broader market.Comparatively, Modular Medical has a beta of 0.45, indicating that its stock price is 55% less volatile than the broader market.

Summary

electroCore beats Modular Medical on 9 of the 15 factors compared between the two stocks.

How does Modular Medical compare to CVRx?

Modular Medical (NASDAQ:MODD) and CVRx (NASDAQ:CVRX) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, media sentiment, earnings, institutional ownership and valuation.

27.5% of Modular Medical shares are owned by institutional investors. Comparatively, 75.3% of CVRx shares are owned by institutional investors. 7.1% of Modular Medical shares are owned by company insiders. Comparatively, 16.6% of CVRx shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Modular Medical has a net margin of 0.00% compared to CVRx's net margin of -84.93%. CVRx's return on equity of -152.35% beat Modular Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Modular Medical	N/A	-292.14%	-222.79%
CVRx	-84.93%	-152.35%	-50.93%

CVRx has a consensus price target of $5.30, indicating a potential upside of 74.34%. Given CVRx's stronger consensus rating and higher possible upside, analysts clearly believe CVRx is more favorable than Modular Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
CVRx	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

In the previous week, Modular Medical and Modular Medical both had 2 articles in the media. Modular Medical's average media sentiment score of 0.64 beat CVRx's score of -0.13 indicating that Modular Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Modular Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Modular Medical has a beta of 0.45, suggesting that its share price is 55% less volatile than the broader market. Comparatively, CVRx has a beta of 0.76, suggesting that its share price is 24% less volatile than the broader market.

Modular Medical has higher earnings, but lower revenue than CVRx. CVRx is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Modular Medical	N/A	N/A	-$28.24M	-$8.69	N/A
CVRx	$56.65M	1.43	-$53.31M	-$1.98	N/A

Summary

CVRx beats Modular Medical on 10 of the 14 factors compared between the two stocks.

Get Modular Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MODD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MODD vs. The Competition

Export

Metric	Modular Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$17.93M	$5.55B	$7.24B	$13.19B
Dividend Yield	N/A	1.80%	2.57%	12.81%
P/E Ratio	-0.25	25.34	275.49	25.40
Price / Sales	N/A	72.49	646.01	89.45
Price / Cash	N/A	32.64	76.25	51.42
Price / Book	0.79	5.69	10.46	6.33
Net Income	-$28.24M	$151.55M	$3.49B	$358.33M
7 Day Performance	-13.39%	0.66%	0.59%	1.12%
1 Month Performance	-35.86%	-3.33%	-1.74%	-2.39%
1 Year Performance	-90.36%	6.79%	18.13%	5.35%

Modular Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MODD Modular Medical	1.1226 of 5 stars	$2.20 +2.3%	N/A	-90.4%	$17.93M	N/A	N/A	51	Gap Up
RNXT RenovoRx	3.4515 of 5 stars	$2.00 -9.1%	$8.50 +325.0%	+27.1%	$90.26M	$1.98M	N/A	6	Positive News Short Interest Decrease High Trading Volume
LUNG Pulmonx	3.2569 of 5 stars	$1.98 -4.8%	$7.67 +287.2%	+22.5%	$85.04M	$87.44M	N/A	250
HYPR Hyperfine	2.3014 of 5 stars	$0.79 -3.8%	$2.03 +157.1%	-45.9%	$83.87M	$16.54M	N/A	190	News Coverage
ECOR electroCore	2.592 of 5 stars	$8.99 -1.0%	$18.00 +100.2%	+135.0%	$81.09M	$32.03M	N/A	50

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MODD) was last updated on 9/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Modular Medical (MODD) Competitors

MODD vs. RNXT, LUNG, HYPR, ECOR, and CVRX

How does Modular Medical compare to RenovoRx?

Summary

How does Modular Medical compare to Pulmonx?

Summary

How does Modular Medical compare to Hyperfine?

Summary

How does Modular Medical compare to electroCore?

Summary

How does Modular Medical compare to CVRx?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MODD vs. The Competition

Modular Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Modular Medical (MODD) Competitors

MODD vs. RNXT, LUNG, HYPR, ECOR, and CVRX

How does Modular Medical compare to RenovoRx?

Do analysts prefer RNXT or MODD?

Which has more risk & volatility, RNXT or MODD?

Is RNXT or MODD more profitable?

Do insiders & institutionals hold more shares of RNXT or MODD?

Does the media refer more to RNXT or MODD?

Which has better earnings and valuation, RNXT or MODD?

Summary

How does Modular Medical compare to Pulmonx?

Which has more risk & volatility, LUNG or MODD?

Which has higher valuation & earnings, LUNG or MODD?

Is LUNG or MODD more profitable?

Do insiders and institutionals hold more shares of LUNG or MODD?

Does the media favor LUNG or MODD?

Do analysts rate LUNG or MODD?

Summary

How does Modular Medical compare to Hyperfine?

Do institutionals & insiders hold more shares of HYPR or MODD?

Is HYPR or MODD more profitable?

Do analysts prefer HYPR or MODD?

Which has more volatility and risk, HYPR or MODD?

Which has higher earnings & valuation, HYPR or MODD?

Does the media favor HYPR or MODD?

Summary

How does Modular Medical compare to electroCore?

Is ECOR or MODD more profitable?

Do institutionals and insiders believe in ECOR or MODD?

Which has better valuation and earnings, ECOR or MODD?

Does the media favor ECOR or MODD?

Do analysts recommend ECOR or MODD?

Which has more risk and volatility, ECOR or MODD?

Summary

How does Modular Medical compare to CVRx?

Do institutionals & insiders have more ownership in MODD or CVRX?

Is MODD or CVRX more profitable?

Do analysts rate MODD or CVRX?

Does the media prefer MODD or CVRX?

Which has more volatility and risk, MODD or CVRX?

Which has higher valuation & earnings, MODD or CVRX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MODD vs. The Competition

Modular Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools